tetradecanoylphorbol acetate and oxamflatin

tetradecanoylphorbol acetate has been researched along with oxamflatin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dear, AE; Medcalf, RL	1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and oxamflatin

Article	Year
The novel anti-tumour agent oxamflatin differentially regulates urokinase and plasminogen activator inhibitor type 2 expression and inhibits urokinase-mediated proteolytic activity. Biochimica et biophysica acta, 2000, Jun-21, Volume: 1492, Issue:1 Topics: Antineoplastic Agents; Gene Expression Regulation, Enzymologic; Humans; Hydroxamic Acids; Nuclear Proteins; Peptide Hydrolases; Plasminogen Activator Inhibitor 2; Promoter Regions, Genetic; RNA, Messenger; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Transcriptional Activation; Transfection; U937 Cells; Urokinase-Type Plasminogen Activator	2000

Article

Year

The novel anti-tumour agent oxamflatin differentially regulates urokinase and plasminogen activator inhibitor type 2 expression and inhibits urokinase-mediated proteolytic activity.

Biochimica et biophysica acta, 2000, Jun-21, Volume: 1492, Issue:1

Topics: Antineoplastic Agents; Gene Expression Regulation, Enzymologic; Humans; Hydroxamic Acids; Nuclear Proteins; Peptide Hydrolases; Plasminogen Activator Inhibitor 2; Promoter Regions, Genetic; RNA, Messenger; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Transcriptional Activation; Transfection; U937 Cells; Urokinase-Type Plasminogen Activator

2000